Home > Insider Trading > Filing (0001209191-20-007151)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1334365	Yuchun Lee	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-04	3,028	$57.27	3,875	No	4	M	Direct
Common Stock	Disposition	2020-02-04	115	$235.15	3,760	No	4	S	Direct
Common Stock	Disposition	2020-02-04	161	$236.19	3,599	No	4	S	Direct
Common Stock	Disposition	2020-02-04	233	$236.99	3,366	No	4	S	Direct
Common Stock	Disposition	2020-02-04	353	$238.94	3,013	No	4	S	Direct
Common Stock	Disposition	2020-02-04	1,026	$239.81	1,987	No	4	S	Direct
Common Stock	Disposition	2020-02-04	112	$241.01	1,875	No	4	S	Direct
Common Stock	Acquisiton	2020-02-05	2,000	$57.27	3,875	No	4	M	Direct
Common Stock	Disposition	2020-02-05	402	$240.59	3,473	No	4	S	Direct
Common Stock	Disposition	2020-02-05	629	$242.03	2,844	No	4	S	Direct
Common Stock	Disposition	2020-02-05	637	$243.13	2,207	No	4	S	Direct
Common Stock	Disposition	2020-02-05	332	$243.78	1,875	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-04	3,028	$0.00	3,028	$57.27
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-05	2,000	$0.00	2,000	$57.27

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,306		2022-09-13	No	4	M	Direct
18,306		2022-09-13	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $235.15 (range $234.86 to $235.50).
Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $236.19 (range $235.90 to $236.44).
Open market sales reported on this line occurred at a weighted average price of $236.99 (range $236.77 to $237.53).
Open market sales reported on this line occurred at a weighted average price of $238.94 (range $238.46 to $239.45).
Open market sales reported on this line occurred at a weighted average price of $239.81 (range $239.48 to $240.14).
Open market sales reported on this line occurred at a weighted average price of $241.01 (range $240.96 to $241.06).
Open market sales reported on this line occurred at a weighted average price of $240.59 (range $240.37 to $240.70).
Open market sales reported on this line occurred at a weighted average price of $242.03 (range $241.53 to $242.52).
Open market sales reported on this line occurred at a weighted average price of $243.13 (range $242.56 to $243.52).
Open market sales reported on this line occurred at a weighted average price of $243.78 (range $243.63 to $243.95).
Fully vested.